Skip to content

Clinical trials

Lysosomal Storage Diseases trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lysosomal Storage Diseases Country / region: Netherlands Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20113
20143
20181
20192
20201
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated2
Active, not recruiting1
Recruiting1
Suspended1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioMarin Pharmaceutical3
Shire3
Spark Therapeutics, Inc.2
Alexion Pharmaceuticals, Inc.1
Amicus Therapeutics1
Denali Therapeutics Inc.1
Gemma Biotherapeutics1
JCR Pharmaceuticals Co., Ltd.1
LYSOGENE1
National Institute of Neurological Disorders and Stroke (NINDS)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lysosomal Storage Diseases15
Mucopolysaccharidosis III4
Mucopolysaccharidosis IV3
Genetic Diseases, Inborn2
Glycogen Storage Disease Type II2
Metabolism, Inborn Errors2
Mucopolysaccharidosis II2
Brain Diseases, Metabolic, Inborn1
Carbohydrate Metabolism, Inborn Errors1
Cholesterol Ester Storage Disease1

Trials

Showing 76 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.